$96.63 - MRUS | Merus N.V. Common Shares

Merus N.V. Common Shares (MRUS)

Merus N.V. Common Shares

XNAS:MRUS

96.63

-0.14%

Ask

$102.00 - 1.00

Bid

$96.60 - 200.00

Low

$96.6

High

$96.79

Open

$96.77

Prev Close

$96.77

52W High

96.83

52W Low

33.19

Volume

1093615

Avg Vol (3m)

1327645.4

Float

70068022.6

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 05/19/2016

Primary Exchange: XNAS

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Phone: 31 030 253 8800

Address: Yalelaan 62

City: 3584 Cm Utrecht

State: DE

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

260

P/E (TTM)

-18.110000

P/B (TTM)

9.456970

Round Lot

100

Share Class Shares Outstanding

75.63M

Weighted Shares Outstanding

75.84M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion